A three-arm randomized trial to compare adjuvant adraimycin and cyclophosphamide followed by taxotere (AC-T); adriamycin and taxotere (AT); and adriamycin, taxotere, and cyclophosphamide (ATC) in breast cancer patients with positive axillary lymph nodes. PI: Howard